Skip to main content
logo
Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
65.16
-2.86 (-4.20%)
At close: Sep 4, 2026, 4:00 PM EDT
66.46
+1.30 (2.00%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Bright Minds Biosciences Income Statement

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Selling, General & Admin
6.182.531.452.22.552.31
Research & Development
32.7411.081.18512.186.31
Operating Expenses
39.1813.612.637.214.738.62
Operating Income
-39.18-13.61-2.63-7.2-14.73-8.62
Interest Expense
-0.05-0.04----
Interest & Investment Income
6.831.520.03---
Currency Exchange Gain (Loss)
8.240.19-0.010.010.010.15
Other Non Operating Income (Expenses)
-0.35-0.29-0.2-0.19-0.24-0.18
EBT Excluding Unusual Items
-24.51-12.23-2.8-7.37-14.96-8.65
Asset Writedown
-----0-
Pretax Income
-24.51-12.23-2.8-7.37-14.96-8.65
Net Income
-24.51-12.23-2.8-7.37-14.96-8.65
Net Income to Common
-24.51-12.23-2.8-7.37-14.96-8.65
Net Income Growth
------
Shares Outstanding (Basic)
974422
Shares Outstanding (Diluted)
974422
Shares Change
38.94%59.58%15.87%50.58%37.64%148.42%
EPS (Basic)
-2.85-1.78-0.65-1.98-6.06-4.82
EPS (Diluted)
-2.86-1.78-0.65-1.98-6.06-4.82
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EBIT
-39.18-13.61-2.63-7.2-14.73-8.62
SEC Filings: 10-K · 10-Q